hotspot -WSS

hotspot

author：knowledge 2025-10-01 11:44:36 - browse：5354

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： WHO recommends second malaria vaccine

hotspot

WSS

The Karikó problem: Lessons for funding basic research

Will an HIV vaccine ever be a reality?

Experimental asthma app from Apple and Anthem shows promise

Will an HIV vaccine ever be a reality?

Nobel honors Karikó and Weissman's enduring partnership

What is STAT's opinion section for?

hotspot

hotspot

focus

Guidelines to prevent youth baseball injuries need more muscle

Congress extends some pandemic preparedness programs

New air purifier tech could be key to improving indoor air quality

After decades in use, heart stents finally beat placebo

23andMe had bad news about my health. I wish a person had delivered it

A letter from the executive editor: STAT UnitedHealth investigation

What does generative AI mean for health care? We asked experts

Ohio still needs to do more to protect the right to abortion

Psychedelics group wrestles with new pharma identity

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

hotspot

WHO recommends second malaria vaccine

Setback for rare diseases as Taysha Gene Therapies pulls back

European officials brace for rough respiratory virus season

With Roe v Wade overturned, abortion providers work to adapt

The stability of $0 premiums in Medicare Advantage

What is STAT's opinion section for?

focus

hotspot

entertainment

knowledge